Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aquacycl develops and deploys modular, distributed biological wastewater treatment systems using its proprietary BETT® bioelectrochemical technology. The system uses natural bacteria to break down organic matter in high-strength industrial wastewaters, generating direct electricity and enabling remote monitoring. The solution reduces greenhouse gas emissions by up to 90% compared to traditional methods and offers significant cost savings for clients. Major commercial deployments include partnerships with global brands like PepsiCo. The company has over eight years of operational experience and more than twenty years of technology development behind its core platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aquacycl.